Not finding it? Sign in to also search OpenAlex live.
-
ABS1115 EFFECT OF A MULTIDISCIPLINARY LIFESTYLE INTERVENTION ON STRESS-RELATED PARAMETERS IN PEOPLE WITH RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS: SECONDARY ANALYSIS OF THE “PLANTS FOR JOINTS” RANDOMIZED CONTROLLED TRIAL2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Johannes A. M. Christiaans, C. Wagenaar, V. Hermans, W. Walrabenstein, Frieda A. Koopman, Henriët van Middendorp, +1 more
0citations -
OP0155 RA RISK GENES ARE DIFFERENTIALLY EXPRESSED BETWEEN (PEAC) PATHOTYPES IN SYNOVIUM WITH A CLEAR ENRICHMENT IN THE LYMPHOID-RICH PATHOTYPE2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Inez C Den Hond, Marcel J. T. Reinders, M. Lewis, Costantino Pitzalis, Rachel Knevel, Erik B. van den Akker
1citations -
OP0254 MICROBIOTA AND CLINICAL RESPONSES TO BIOLOGICAL TREATMENT IN AXIAL SPONDYLOARTHRITIS: INSIGHTS FROM 2 YEAR FOLLOW UP OF THE GESPIC COHORT2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Valeria Ríos Rodríguez, M. Essex, Murat Torğutalp, Fabian Nikolai Proft, H. Haibel, Mikhail Protopopov, +4 more
0citations -
MOTION: A randomized, phase 3, placebo-controlled, double-blind study of vimseltinib (DCC-3014) for the treatment of tenosynovial giant cell tumor.2022 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments cited by 11 patents
William D. Tap, Andrew J. Wagner, Maitreyi G. Sharma, Marc Vallee, Mary F. Michenzie, Matthew Leigh Sherman, +4 more
3citations -
A Phase 3, Randomized, Double-Blind, Active-Comparator-Controlled Study of Bomedemstat Versus Hydroxyurea in Patients with Essential Thrombocythemia Naïve to Cytoreductive Therapy2024 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Yuka Sugimoto, Eran Zimran, Yoshimitsu Shimomura, Hiroki Yamaguchi, Hans Carl Hasselbach, Jean‐Jacques Kiladjian, +14 more
2citations -
Patient-Reported Outcomes: Danicopan As Add-on Therapy to Ravulizumab or Eculizumab Versus Placebo in Patients with Paroxysmal Nocturnal Hemoglobinuria and Clinically Significant Extravascular Hemolysis2023 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Caroline Irene Piatek, Jong Wook Lee, Morag Griffin, Jun‐ichi Nishimura, Christopher Jordan Patriquin, Hubert Schrezenmeier, +9 more
0citations -
INTRIGUE: A phase III, randomized, open-label study to evaluate the efficacy and safety of ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib2022 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
Michael Charles Heinrich, Robin L. Jones, Hans A. J. Gelderblom, Suzanne George, Patrick Schöffski, Margaret von Mehren, +13 more
18citations -
Treatment of multiple traumatized adolescents by enhancing regulation skills and reducing trauma related symptoms: rationale, study design, and methods of randomized controlled trial (the Mars-study)2023 BMC Psychiatry conference-abstract Psychology Posttraumatic Stress Disorder Research Open access
Rik Knipschild, Helen Klip, Doenja Leeuwaarden, Mariken J. R. van Onna, Ramón Lindauer, Wouter Staal, +1 more
8citations -
THE DANTON STUDY - DISCONTINUATION OF ANTIHYPERTENSIVE TREATMENT IN OLDER PEOPLE WITH DEMENTIA LIVING IN A NURSING HOME: RESULTS OF A RANDOMIZED CONTROLLED TRIAL2022 Journal of Hypertension conference-abstract Medicine Dementia and Cognitive Impairment Research
Jonathan M. K. Bogaerts, Jacobijn Gussekloo, Bianca E M de Jong-Schmit, Wilco P. Achterberg, Rosalinde K. E. Poortvliet
5citations -
Efficacy, safety, and patient-reported outcomes of vimseltinib in patients with tenosynovial giant cell tumor: Results from the phase 3 MOTION trial.2024 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments Open access cited by 11 patents
William D. Tap, Vivek A. Bhadri, Silvia Stacchiotti, Sebastian Bauer, Andrew J. Wagner, Michiel A. J. van de Sande, +14 more
2citations -
OS05.4.A Do neurocognitive deficits explain the differences between brain tumour patients and their proxies assessing the patient’s I-ADL?2021 Neuro-Oncology conference-abstract Medicine Cancer-related cognitive impairment studies Open access
Quirien Oort, Linda Dirven, Sietske A.M. Sikkes, Neil K. Aaronson, Florien Willemijn Boele, Christine Brannan, +10 more
0citations -
COL14: A compiled radiocarbon dataset for Colombia2026 Zenodo (CERN European Organization for Nuclear Research) conference-abstract Earth and Planetary Sciences Archaeology and ancient environmental studies Open access
Sebastian Fajardo, Natalia Álvarez Correa, A. Jacobo Hidalgo, Rodolfo Cepeda, Nicolás Loaiza, Carlos Reina, +2 more
0citations -
COL14: A compiled radiocarbon dataset for Colombia2026 Zenodo (CERN European Organization for Nuclear Research) conference-abstract Earth and Planetary Sciences Archaeology and ancient environmental studies Open access
Sebastian Fajardo, Natalia Álvarez Correa, A. Jacobo Hidalgo, Rodolfo Cepeda, Nicolás Loaiza, Carlos Reina, +2 more
0citations -
Severe cognitive effects of avapritinib: Towards a mechanistic understanding.2026 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment Open access
Joris M. van Sabben, Hans Gelderblom, Franck Lebrin, Jérémy H. Thalgott, Annette Compter, Louise van der Weerd, +6 more
0citations